Many Parents Do Not Plan to Vaccinate Youngest Child for COVID-19
49.4 percent of parents surveyed in one study and 61.9 percent in second study intend to vaccinate youngest
Antibody Combo Prevents Infection From SARS-CoV-2 Exposure
Single dose of REGEN-COV reduces symptomatic, asymptomatic infection risk in household contacts of infected persons for 28-day period
COVID-19 Vaccines Seem Safe in Rheumatic, Musculoskeletal Disease Patients
Disease flare requiring treatment reported in 11 percent following two-dose mRNA SARS-CoV-2 vaccination, with no reports of severe flare
22.1 Percent of U.S. Adults With Chronic Pain Use Rx Opioids
Prescription opioid use highest for those aged 45 to 64 years; more likely among women, unemployed adults
Pharmacomechanical Thrombolysis for Acute DVT Tied to Kidney Injury
Bilateral deep vein thrombosis, single-session treatment, and female sex tied to greater risk
Moderna Vaccine’s Protection Does Not Wane After Six Months: Report
Moderna's statement came from a new analysis of its ongoing clinical trial
Largest Operator of Nursing Homes in U.S. Issues Vaccine Mandate for All Workers
Employees have until Aug. 23 to get their first shot
WHO Slams COVID-19 Booster Shots in Wealthy Nations
Agency calls for a moratorium on booster shots until at least the end of September
REGEN-COV Authorized for Postexposure Prophylaxis in High-Risk Individuals
Emergency use authorization indicated for those who have been exposed to SARS-CoV-2 and have an immunocompromising condition
Full Approval of Pfizer COVID-19 Vaccine Could Come in September
FDA said in a statement that its leaders recognized that full approval might counter vaccine hesitancy
